INTRODUCTION
Sodium (Na) homeostasis is crucial for life, and Na levels in body fluids are constantly monitored in the brain (Andersson, et al., 1982) . Appropriate responses to an elevation of the serum Na level are greater water intake stimulated by thirst and minimum excretion of concentrated urine caused by the secretion of antidiuretic hormone (ADH; vasopressin) (Votey et al., 1989) . If these regulatory mechanisms are impaired, Na levels in body fluids should be chronically increased. Hypernatremia, defined as a rise in the plasma Na concentration to a value exceeding the physiological level ($145 mM), is a common electrolyte disorder (Lin et al., 2005; Baylis and Thompson, 1988) , with mortality rates ranging from approximately 40% to more than 60% (Palevsky, 1998) .
''Essential hypernatremia'' is clinically characterized by upward resetting of both the osmotic set point for vasopressin release and the threshold for thirst perception, resulting in persistent hypernatremia with a euvolemic state (Avioli et al., 1962; DeRubertis et al., 1974; Welt, 1962) . Usually, structural abnormalities in the hypothalamic-pituitary area, as a result of trauma, tumors, or inflammation, are detected. However, several cases of essential hypernatremia without demonstrable hypothalamic structural lesions have been reported, although the precise mechanism or mechanisms have not been elucidated (Bappal et al., 2006; Cauble et al., 2001; Conley et al., 1976; duRivage et al., 1985; Hayek and Peake, 1982; Schaad et al., 1979) .
We previously reported, based on a battery of studies on Na xknockout (Na x -KO) mice, that Na x channel is the Na-level sensor of body fluids in the brain (Hiyama et al., , 2004 Noda, 2006 Noda, , 2007 Noda and Hiyama, 2005; Watanabe et al., 2000) . Na x is an atypical Na channel whose structure is poorly homologous to the voltage-gated Na channels (Goldin et al., 2000) that is expressed in the posterior pituitary and three circumventricular organs (CVOs) in the brain: the subfornical organ (SFO), organum vasculosum of the lamina terminalis (OVLT), and median eminence (ME) (Watanabe et al., 2000 (Watanabe et al., , 2006 . The Na x channel is a concentration-sensitive Na channel with a threshold value of $150 mM for the extracellular Na ion . Na x -KO mice do not stop ingesting salt when dehydrated, whereas wild-type (WT) mice avoid salt (Hiyama et al., 2004; Watanabe et al., 2000) . Unlike in WT mice, salt-aversive behavior does not occur upon the direct infusion of a hypertonic Na solution into the cerebral ventricle in Na x -KO mice (Hiyama et al., 2004) . The abnormal salt intake pattern of Na x -KO mice was rescued by a sitedirected transfer of the Na x gene with an adeno-viral vector into the SFO (Hiyama et al., 2004) . These findings obtained with Na x -KO mice led us to speculate that there could be patients with hypernatremia whose Na-level sensory system is impaired for some reason.
In the present paper, we report a patient with essential hypernatremia who developed autoantibodies to Na x . The patient had a ganglioneuroma that was mainly composed of Na x -positive Schwann-like cells, and this neoplasia likely evoked an antitumor immune response. Passive transfer of the immunoglobulin (Ig) fraction of the patient's serum reproduced her symptoms with abnormal reductions in water intake and vasopressin-release in WT mice, most likely due to the complement-mediated cell death in the CVOs where Na x is expressed. Her symptoms thus suggest a paraneoplastic neurologic disorder (PND) characterized by neurologic dysfunction in the setting of a remote cancer. Our study shows, for the first time, that autoimmunity to the Na-level sensor Na x causes chronic hypernatremia.
RESULTS

A Patient with Adipsic Hypernatremia
A 6.5-year-old Asian girl was admitted to Tokai University Hospital because of general fatigue and fluctuating drowsiness persisting for a week. Past history revealed no perinatal problems, with a birth weight of 2940 g at 41 weeks of gestation. No developmental delay was noted. Her growth was unremarkable except for obesity. Physical examination on admission revealed a rather chubby-looking girl (115 cm [+0.2 SD] in height, 29.6 kg [+2.3 SD] in weight), with normal blood pressure (110/ 70 mmHg), tachycardia (132 beats/min), prompt capillary refilling, and normal skin turgor. She had no pretibial pitting edema. No clinical evidence of severe dehydration was noted. Clinical features of precocious puberty were absent. Neurological examination revealed a slightly impaired consciousness, a score of 1 (awake without any stimuli, and almost fully conscious) on the Japan Coma Scale, normal muscular tonus, no muscular weakness, and no sensory disturbances. We found that she had marked hypernatremia with a serum Na concentration as high as 199 mM ( Figure 1A , day 1). Of note, she did not complain of any thirsty sensation despite such extreme hypernatremia.
The results of clinical tests are summarized in Table S1 in the Supplemental Information (available online). Blood urea nitrogen, creatinine, and albumin levels were elevated, along with the marked elevation of her serum Na concentration, suggesting dehydration to some extent, although this was hardly detectable by physical examination. Endocrinological tests were unremarkable except for vasopressin, prolactin, and plasma renin activity. Notably, her vasopressin level of 2.1 pg/ml should be interpreted as rather low, considering her serum Na concentration of 199 mM. A slight elevation in the concentration of prolactin is insufficient for the diagnosis of prolactinoma, in which the serum prolactin level usually exceeds 100 ng/ml. Thyroid function was normal. Hypernatremia due to Cushing's syndrome or primary aldosteronism was ruled out, because cortisol and adrenocorticotropic hormone (ACTH) levels were within the normal range, and her aldosterone level was low. Urinalysis revealed the following: pH 5.0, specific gravity 1.038, protein (1+), occult blood (-), and glucose (-). The fractional excretion of Na was 1.34%.
Clinical Treatments for the Patient
Intravenous infusion therapy (day 1-8) with a series of hypotonic fluids resulted in a gradual decrease in her serum Na concentration without the development of convulsions ( Figure 1A) ; the clinical course and compositions of the fluids are shown in Figure S1 (available online) and in the ''Intravenous Infusion in the Patient'' subsection in the Supplemental Information. Her serum Na concentration was 142 mM on day 8, with concomitant decreases in hematocrit (31.2%), creatinine (0.4 mg/dl), and blood urea nitrogen (17 mg/dl) values, and with a slight increase (1.0 kg) in body weight. Along with the decrease in her serum Na concentration, her creatine phosphokinase level and platelet count were normalized to 89 IU/l and 21.8 3 10 4 /ml, respectively, on day 10. The proteinuria disappeared on day 2. Although her urine output before admission was unknown, her urine volume during the initial 4 hr of fluid therapy starting on admission was 125 ml (i.e., 1.05 ml/kg/hr). Her urine volume thereafter was also kept substantial, around 700 to 1000 ml/day (mean 845 ml/day). Abdominal ultrasonography and magnetic resonance imaging (MRI) revealed a solid tumor adjacent to the right adrenal gland. The retroperitoneal tumor was surgically removed on day 14 ( Figure 1B ), on the assumption that the tumor was somehow related to her extreme hypernatremia. The histological diagnosis of the retroperitoneal tumor was ganglioneuroma, composed of abundant Schwann-like cells along with some ganglion cells ( Figure 1C ).
For the surgery, the patient again received infusions from day 14 to 20 and her serum Na level was stabilized in the normal range ( Figure 1A , day [16] [17] [18] [19] [20] . However, when the infusion was discontinued, her serum Na level slightly increased again (156 mM on day 27; 155 mM on day 31). Resumption of the hypotonic infusion from day 35 to 37 decreased the serum Na concentration to the normal level; however, stopping the infusion reproducibly resulted in an increase (161 mM on day 44). From day 44, the patient was instructed to drink 1000-1500 ml of water per day (day 44-78), and her serum Na level became relatively stable in the range of 145-155 mM (day 46-78). We placed the patient on ad libitum water intake from day 79, and she stayed home on days 81 and 82. This caused an elevation in her Na level to 162 mM (day 84), indicating that the serum Na level highly depends on water intake and that the patient's hypernatremia was not cured by the removal of the tumor. Then we again instructed the patient to drink a sufficient amount of water from day 84. After leaving the hospital on day 106, the patient has been directed to drink 1500-2000 ml of water/day. However, her serum Na level continues to fluctuate even now, 4 years after removal of the tumor ( Figure 1D ).
Tests to Delineate the Pathological Condition and Etiology
To investigate whether an inadequate urine-concentrating ability could be an underlying etiology of the persistent hypernatremia, a vasopressin loading test and a fluid deprivation test were performed 3 and 11 months after the surgery, respectively. Intranasal administration of 10 mg of a vasopressin analog, 1-deamino-8-arginine-vasopressin (dDAVP), resulted in an increase in urinary osmolality from 348 to 708 mOsm in 6 hr. Further, her urine osmolality was 847 mOsm after overnight fluid deprivation (16 hr), and with an additional 4 hr fluid deprivation (i.e., 20 hr in total) it reached 1009 mOsm, indicating that the urine-concentrating ability of the patient's kidney was intact. Again, she did not complain of thirst during the fluid deprivation test. She remained obese even after the surgery, with a tendency toward hyperphagia and hyperhidrosis. The hyperhidrosis may contribute to the loss of free water in this patient.
To examine the possibility of inadequate vasopressin release, the relationship between serum osmolality and the plasma vasopressin level obtained during a 4-year follow-up was plotted ( Figure 1E ). The data clearly showed that a normal increase of Figure S1 . The patient underwent surgery to remove the ganglioneuroma on day 14. Instructions regarding the amount of water to drink (green and red lines) were suspended from day 79 to 83 and the patient stayed home from day 81 to 82. (B) Whole image of the removed ganglioneuroma tissue. Scale bar, 5 mm. (C) Hematoxylin eosin staining of a section of the ganglioneuroma. Round-shaped ganglion cells (arrows) are surrounded by Schwann-like cells. (D) Serum Na level of the patient after her discharge from the hospital. The abscissa indicates month/year from the day the patient was admitted to the hospital. I, II, and III indicate the days when the sera used for experimental analyses were collected. The total IgG concentration in the patient's sera was 12.65, 11.05, and 10.64 (mg/ml) for serum I, II, and III, respectively. (E) Relationship between the serum osmolality and plasma vasopressin level obtained during a 4-year follow-up of the patient. The green area indicates the normal range.
vasopressin secretion in response to serum hyperosmolality is lacking in this patient. Impaired secretion of vasopressin, along with adipsia, was considered to have greatly contributed to the development of persistent hypernatremia. Adipsia, hypernatremia, obesity, and disrupted vasopressin secretion led us to diagnose the patient as having essential hypernatremia, synonymous with adipsic hypernatremia or hypodipsia-hypernatremia syndrome (Avioli et al., 1962; DeRubertis et al., 1974; Welt, 1962) .
In most cases of essential hypernatremia reported to date, significant intracerebral pathology was present, with presumed damage to the relevant hypothalamic regions. However, we could not detect a structural anomaly such as a space-occupying lesion within the brain of the patient by MRI, with special concerns in the hypothalamus and pituitary gland ( Figure S2 ), suggesting essential hypernatremia without demonstrable intracranial structural lesions.
Serum of the Patient Contains Autoantibodies to Na x
The marked increase in the serum Na level without any feeling of thirst or Na aversion suggested functional defects in the Na-level-sensing mechanism in the brain. In her clinical records 1 year before her admission to the hospital, when the patient was referred to a local clinic because of obesity, her plasma Na level was normal (138 mM). Because her parents and only brother have no history of hypernatremia, it was unlikely that she had some genetical problem. Indeed, there existed no significant mutations in the exons by genomic sequencing covering 25 exons of the Na x gene of the patient (data not shown). Instead, because she was harboring a retroperitoneal tumor, we suspected that the generation of an autoantibody against the Na-level sensor or osmotic sensor impaired the mechanism of monitoring the condition of body fluids.
To test this idea, we developed a C6 rat glioblastoma cell line, C6H17, in which the expression of human Na x channels is inducible under the control of the tetracycline-responsive element (TRE). In this cell line, Na x expression is induced by a transactivator, Tet-Off, which is transfected and expressed with an adenoviral vector. The membrane extracts of the cells were subjected to western blotting with the patient's serum taken at the time point of 8 months after the admission to the hospital (indicated by an arrow marked with I in Figure 1D ). A band around 200 kDa, the appropriate size for Na x , was specifically detected in the extract of the cells expressing Na x (Figure 2A , left, +). This signal was absent in the extract of the cells without Na x expression ( Figure 2A , left, -). When the membrane was reprobed with control human serum, no band was detected (Figure 2A , right). We further tested 10 serum samples from age-and sex-matched control subjects, but all were negative for anti-Na x (data not shown), strongly suggesting that the presence of the autoantibody to Na x is a specific feature of this patient.
The patient's antibody could also detect mouse Na x ( Figure 2B ), but not human Na v 1.7, the Na channel most closely related to Na x structurally ( Figure S3 ). Thus, the epitope recognized by the patient's autoantibody was considered to be common to human and mouse Na x , but not widely shared by the members of the sodium-channel family. Besides the Na-level-sensing mechanism, TRPV1 and TRPV4 were recently suggested to be involved in osmosensing mechanisms of body fluids (Bourque, 2008; Liedtke, 2008) , but neither anti-TRPV1 nor anti-TRPV4 autoantibody was detected in the patient's serum (Figures 2C and 2D) .
To identify the epitope region for the autoantibody, we next performed immunoblotting against a peptide array spotted with overlapping sequences corresponding to the extracellular region of human Na x . The list of peptides is shown in Table S2 . The serum from the patient reacted strongly with two neighboring spots containing an overlapping sequence ( Figure 2E , closed bar), located in the vicinity of the pore-forming region of the third domain of Na x ( Figure 2F , closed arrow). The serum also reacted weakly with another set of neighboring spots ( Figure 2E , open bar), located in the vicinity of the pore-forming region of the second domain of Na x ( Figure 2F , open arrow).
The subclass of the autoantibody against Na x in the patient was determined to be IgG1 by western blotting ( Figure 2G ). In addition to the patient's serum I, we later examined the other two blood samples taken from the same hypernatremia patient at the time points of II and III in Figure 1D . We found that these sera still detect human Na x proteins on western blotting, though the titer was not constant ( Figure 2H ). This was confirmed by immunocytochemistry of C6H17 cells expressing human Na x (data not shown).
The Tumor Removed from the Patient Is Positive for Na x
If the development of the neoplasia triggered the emergence of the autoantibody, the tumor should contain cells strongly expressing Na x . To test this notion, tissue sections of the ganglioneuroma removed from the patient were examined with the rabbit polyclonal anti-Na x , along with the expression of a Schwann cell marker, S-100 ( Figure 2I ). The ganglioneuroma was markedly positive for both Na x and S-100. The Na x signal colocalized with the S-100 signal at the cellular level, indicating that Schwann-like cells in the tumor express Na x .
We also examined the expression of Na x in other ganglioneuromas developed in the vicinity of the adrenal gland in three independent patients without hypernatremia: one is shown in Figure 2I and the other two are shown in Figure S4 . S-100 was positive in all of them, but Na x was negative, indicating that abnormal Schwann cells in ganglioneuromas are usually deficient in Na x expression. That is, Na x is irregularly expressed in the ganglioneuroma of this patient with hypernatremia. This coincidental occurance of the Na x -positive neoplasm and the autoantibody against Na x in the same patient led us to suppose that the hypernatremia of this patient is an unidentified phenotype of a PND.
The Autoantibodies Recognize the Native Form of Na x Immunocytochemistry of C6H17 cells with or without the expression of human Na x using the patient's serum indicated that the autoantibodies react to the native form of Na x : intense signals were observed in the plasma membrane of the cells only when the expression of Na x was induced ( Figure 3A ; Patient serum I, compare Na x + and -). The reactivity of the serum was completely abolished by preincubation with synthetic peptides containing the identified epitopes of Na x ( Figure 3A , Patient serum I, Na x peptides), but not with scrambled peptides ( Figure 3A , Patient serum I, Control peptides), confirming the specificity of the autoantibodies to Na x . There was no staining in C6H17 cells expressing Na x with the control serum ( Figure 3A , Control serum), nor with an additional 10 control sera (data not shown).
We examined the effect of the binding of autoantibodies using dissociated Na x -expressing SFO cells of WT mice. The cells were incubated with the serum from the patient or serum from a healthy subject for indicated times, and then fixed to examine the subcellular distribution of Na x by immunostaining with the rabbit polyclonal anti-Na x antibody ( Figure 3B ). Na x was found at the plasma membrane at first ( Figure 3B , 0 min), as we previously reported (Shimizu et al., 2007) . However, its distribution gradually changed, moving into the cell upon incubation with the patient's serum in a time-dependent manner, but this was not the case with the control serum ( Figure 3B ). The distribution profiles indicated the intracellular translocation of Na x at 60 min (E) Epitope mapping for the anti-Na x autoantibodies in the patient using a peptide array. Major signals were detected at spots #24 (VMNKSRCESLLF) and #25 (CESLLFNESMLW) indicated by a closed bar. Minor signals were at #18 (GEWVETLWDCME) and #19 (LWDCMEVAGQSW) with an open bar. They correspond to the regions of Na x indicated by open and closed arrows, respectively, in (F). The peptides spotted on the array are shown in Table S2 .
(F) Schematic illustration of human Na x . The red box with a closed arrow in the vicinity of the pore-forming region in domain III indicates the location of the amino acid sequence overlapping between peptides #24 and #25. The red box with an open arrow indicates the location of the sequence of peptides #18 and #19. P, putative pore-forming regions.
(G) The subclass of the autoantibodies to Na x . The membrane extract of C6H17 cells with (+) or without (-) expression of human Na x was analyzed using the patient's serum I as the primary antibody and anti-human IgM, IgG1, IgG2, IgG3, or IgG4 as the secondary antibody.
(H) Western blot analyses of the extracts of C6H17 cells with (+) or without (-) expression of Na x using the sera from the hypernatremia patient at the time point of I, II, and III (see Figure 1D ) at 1:1000 and 1:5000 dilutions.
(I) Expression of Na x (green) and S-100 (red) in the ganglioneuroma removed from the patient with hypernatremia. Na x expression was negative in a ganglioneuroma from a patient without hypernatremia (for additional controls, see also Figure S4 ). Scale bars, 100 mm.
upon incubation with the patient's serum, but not upon that with the control serum ( Figure 3C ).
The Autoantibodies React with the Circumventricular Organs
Because the patient's antibodies also recognize mouse Na x channels (Figures 2A and 2B ), we next tried to establish an animal model of the disease of this patient. Prior to the animal study, we checked whether the autoantibody can bind to the Na x -positive cells at the tissue level. When mouse brain sections were immunostained with the patient's serum, the SFO and OVLT, representative sites expressing Na x , were specifically stained in the sections of WT mice, but not those of Na x -KO mice ( Figure 3D ). In addition to these sites, the ME and posterior pituitary expressing Na x were immunostained again only in WT mice (data not shown). The specific staining of Na x -positive regions in the brain is also indicative of the specificity of autoantibodies to Na x , because other members of voltage-gated Na channels including Na v 1.1, 1.2, and 1.3 are intensively expressed in the brain (Beckh et al., 1989) . Control experiments using sera of age-and sex-matched control subjects (from 10 individuals) produced no detectable staining in brain sections of WT mice (data not shown).
Intravenous Injection of the Patient's Ig Fraction Induces Hypernatremia in Mice
We examined the pathophysiological effects of the autoantibody to Na x by intravenously injecting WT mice with the patient's Ig fraction. After 1 week, we found that the mice took in significantly less water than those given the vehicle or control Ig under nonfeeding conditions ( Figure 4A ). To show that this effect was caused by the anti-Na x autoantibody, we removed the (D) Strategy of the food preference test. Mice were injected with Vehicle or Ig preparations 7 days before the test (day -9) and housed under usual conditions (day -9 to day -3). From day -2 to day 10, Na-depleted food and Na-repleted food were served, and the mice could take them ad libitum. The amount of drinking water was restricted to 0.5 ml/day from day 0 to 3. (E) Preference ratios for Na-repleted food. *p < 0.05 (compared with Vehicle), # p < 0.05 and ## p < 0.01 (compared with Control Ig), by two-tailed t test; data are the mean and SE (n = 8 for each). (F) Preference ratios for Na-repleted food. # p < 0.05 [compared with Patient Ig (Control-abs)], by two-tailed t test; data are the mean and SE (n = 8 for each).
(G) Plasma Na levels of the mice at day 0, 3, 4, 5, and 10 in (E) and at day 3 and 10 in (F). *p < 0.05 and **p < 0.01 (compared with Vehicle), # p < 0.05 and ## p < 0.01
[compared with Control Ig or Patient Ig (Control-abs)], by two-tailed Mann-Whitney test; data are the mean and SE (n = 4 for each).
Neuron
Autoimmunity to Na Sensor Causes Hypernatremia autoantibody in the patient's Ig using affinity resins conjugated with Na x -epitope peptides ( Figures 2E and 2F ). After adequate absorption of the autoantibody ( Figure S5 ), the depleted patient's Ig preparation was almost ineffective [ Figure 4A , Patient Ig (Na x -abs)], whereas the preparation absorbed with control peptides remained effective [ Figure 4A , Patient Ig (Control-abs)]. Because the patient showed an abnormal reduction in vasopressin release (Figure 1E) , the plasma vasopressin level of the mice was examined under hydrated (water-satiated) and dehydrated conditions. No differences were found among the three groups under hydrated conditions ( Figure 4B , Hydrated). After 24 hr of dehydration, the vasopressin level of the mice injected with the patient's Ig was elevated but significantly lower than that of the mice given the vehicle or control Ig ( Figure 4B , Dehydrated). Consistent with this finding, the amount of urine of the patient-Ig-injected mice during 24 hr of dehydration was significantly larger than that of the mice given the vehicle or control Ig ( Figure 4C , Dehydrated). The absorption of the anti-Na x autoantibodies eliminated the ability to affect urine upon dehydration ( Figure 4C , Dehydrated).
We know that Na x -KO mice do not stop ingesting salt when dehydrated (Watanabe et al., 2000; Hiyama et al., 2004) . Therefore, we examined the effect of the patient's Ig on salt intake behavior: the mice treated were allowed free access to both normal (Na-repleted) and Na-depleted food under conditions where the amount of drinking water was restricted to 0.5 ml/day ( Figure 4D ). Before water was restricted, each group of mice showed almost the same preference for normal and Na-depleted food ( Figures 4E and 4F , day À2, À1, and 0). During the water restriction, the mice that received the vehicle, the control Ig, or the patient's Ig absorbed with the Na x peptides [Patient Ig (Na x -abs)] progressively showed a preference for Na-depleted food ( Figures 4E and 4F After water restriction for 3 days, the plasma [Na + ] reached over 160 mM in the groups given Patient Ig or Patient Ig (Control-abs), while it remained at a physiological level in those given vehicle, control Ig, or Patient Ig (Na x -abs) ( Figure 4G , day 3). On repletion with enough water, the preference for Na-depleted food of the groups given vehicle, control Ig, or Patient Ig (Na x -abs) recovered to the normal level within 1 day ( Figures 4E and 4F , day 4), and importantly, their plasma [Na + ]
remained at the basal level during the test ( Figure 4G , day 4). In contrast, the groups given Patient Ig or Patient Ig (Controlabs) showed slightly but significantly higher levels of [Na + ] in plasma even 1 week after water repletion ( Figure 4G , day 10).
High Plasma Na + Levels by Excessive Salt Intake in the Two-Bottle Test We confirmed the abnormality in salt intake with another experimental strategy using a two-bottle test with pure water and hypertonic saline ( Figure 5A ): 1 week after the intravenous injection with the patient or control Ig, the mice underwent the two-bottle test directly (Hydrated) or following dehydration for 2 days (Dehydrated). When hydrated, the three groups of mice ingested nearly equal amounts of water and hypertonic saline ( Figure 5B, Hydrated) . When dehydrated, the mice injected with the vehicle and control Ig preferred pure water and avoided the hypertonic saline, and the preference ratio for 0.3 M NaCl was markedly reduced ( Figure 5B , Vehicle and Control Ig, Dehydrated). However, the mice injected with the patient's Ig took pure water and 0.3 M NaCl almost equally, and the preference ratio for 0.3 M NaCl was not reduced ( Figure 5B , Patient Ig, Dehydrated). The total fluid intake was equally increased in the three groups after dehydration ( Figure 5C ).
After the dehydration, the plasma [Na + ] in the three groups increased to the same level ( Figure 5D , Dehydrated, i). In the dehydrated strategy, the plasma [Na + ] of mice injected with the vehicle and control Ig recovered to the basal level at once in the two-bottle test ( Figure 5D , Vehicle and Control Ig, Dehydrated, ii, iii, and iv). In contrast, the plasma [Na + ] of mice injected with the patient's Ig did not recover to the basal level soon under the same condition, and remained at significantly high levels during 1 week ( Figure 5D , Patient Ig, Dehydrated, ii, iii, and iv). Thus, injection of the patient's Ig reproduced the persistent hypernatremia in mice as observed in the patient.
Injection of Patient's Ig Leads to Complement Deposition and Infiltration of Inflammatory Cells in Na x -Positive Regions in the Mouse Brain
Because some irreversible defects supposedly occurred in the Na x -positive regions of the mice injected with the patient's Ig fraction, we next examined tissue damage of Na x -positive regions in the mouse brain. First of all, we tried to detect deposition of the injected patient's Ig in the Na x -positive regions of the mouse brain. Brain sections were prepared from the mice 3 days after the injection of the patient's Ig, and were immunostained with anti-human IgG antibody ( Figure 6A ). Significant signals for human IgG were found specifically in the Na x -positive regions including the SFO and OVLT of the mice injected with the patient's Ig, but not of those injected with the control Ig. In contrast, no signal for human IgG was observed in the supraoptic nucleus (SON), paraventricular nucleus (PVN), or choroid plexus, where Na x is not expressed. Because the human IgG1 subclass is known to activate complement reactions (Mix et al., 2006) , we then examined deposition of the complement component C3 in the brains of mice injected with the patient's Ig. It was clearly positive in the SFO and OVLT where Na x is expressed ( Figure 6B , Patient Ig), but negative in the SON or PVN where Na x is not expressed. Importantly, choroid plexus, a place deficient in blood-brain barrier (BBB) and Na x expression, was negative for C3 staining. On the other hand, in the mice treated with control Ig, the C3 staining was not detectable in any regions tested ( Figure 6B , Control Ig). These results suggested that complement was specifically deposited where human Igs reacted with the relevant antigen.
It is well established that complement plays a detrimental role in the acute inflammatory response following the attack on selftissues by autoantibodies (Tsokos, 2003) . As was expected, signals of CD68, a marker for reactive microglia and macrophages (Damoiseaux et al., 1994; Greaves and Gordon, 2002) , and the P2Y 12 receptor, a specific marker for reactive microglia (Sasaki et al., 2003) , were observed in the Na x -positive SFO, OVLT, and posterior pituitary 3 days after the injection of the patient's Ig ( Figure 6C ; as for the ME, see Figure S6 ). In the same mouse, however, the Na x -negative regions such as SON, PVN, and choroid plexus were negative for these inflammatory cells (data not shown). No signal for CD68 or P2Y 12 was observed in the mice injected with the control Ig (data not shown).
Injection of Patient's Ig Induces Cell Death in Na x -Positive Regions in the Brain
Deposition of the C3 component and infiltration of inflammatory cells are apparent signs of cytolysis within the Na x -positive regions in the murine model. Thus, a major pathophysiological feature in the mouse model appeared to be persistent focal damage in the CVOs, the center for sensing the condition of body fluids. So we assessed the cell death in the brains of the mice 3 days after the injection of the patient's Ig or the control Ig. Complement-mediated cell death reportedly occurs through both necrosis and apoptosis (Nauta et al., 2002) .
For the detection of necrotic cell death, we performed propidium iodide (PI) staining because necrotic cells in parenchyma of the brain are reportedly stained by the intracerebroventricular administration of PI (Unal Cevik and Dalkara, 2003) . In the mice injected with the patient's Ig, we found significant cell death in the SFO and OVLT where Na x is expressed, but almost no cell death in the SON, PVN, or choroid plexus where Na x is not expressed ( Figures 7A and 7C, Patient Ig) . The number of PI-positive cells in the SFO and OVLT was prominent in the patient-Ig-injected mice compared with the control-Ig-injected mice ( Figure 7C ). In the mice treated with the control Ig, PI-positive cells were scarcely detected in any of these regions ( Figures  7A and 7C, Control Ig) .
We also carried out terminal deoxynucleotidyl transferasemediated dUTP nick-end labeling (TUNEL) assays, which label cells undergoing apoptosis and some forms of nonapoptotic cell death (de Torres et al., 1997) . TUNEL-positive cells were also observed specifically in the Na x -positive SFO and OVLT after the injection of the patient's Ig, but not in Na x -negative regions such as the SON, PVN, or choroid plexus ( Figures 7B  and 7D , Patient Ig). Signals were not observed in any of these regions in the mice injected with the control Ig ( Figures 7B and  7D , Control Ig). Taken together with the PI-staining data, both necrosis and apoptosis are evident in the Na x -expressing regions of the CVOs in the mice injected with the patient's Ig.
DISCUSSION
The association of hypernatremia with neurologic disorders has been known for some time now, because the majority of patients (D) Plasma Na + levels of the mice just before (i), just after (ii), 24 hr after (iii), or 7 days after (iv) the two-bottle tests (see experimental strategy in A). *p < 0.05 and **p < 0.01 (compared with Vehicle), # p < 0.05 and ## p < 0.01 (compared with Control Ig), by two-tailed Mann-Whitney test; data are the mean and SE (n = 5 for each).
with essential hypernatremia have anatomic lesions in their CNS to account for these abnormalities (Avioli et al., 1962; DeRubertis et al., 1974; Welt, 1962) . However, some cases were described in the literature in which no demonstrable hypothalamic structural lesion was identified (Bappal et al., 2006; Cauble et al., 2001; Conley et al., 1976; duRivage et al., 1985; Hayek and Peake, 1982; Schaad et al., 1979) . Intriguingly, the patients reported so far as having essential (or adipsic) hypernatremia without demonstrable intracranial lesions are all under 13 years of age (4-12 years old). This finding has suggested the presence of a distinct syndrome with altered hypothalamic function of unknown etiology (Hayek and Peake, 1982) . In the present study, we identified a patient with essential hypernatremia without a demonstrable intracranial lesion. In our patient, although the symptoms became apparent in a short period before admission, the hypernatremia had supposedly developed in a very insidious manner, with mild to moderate elevations of the Na level and without any remarkable symptoms at first. Then severe hypernatremia became apparent enough to be symptomatic, probably triggered by some factor or factors that influenced the amount of water intake or amount of free water loss, such as perspiration. The reason for this speculation is that the severity of her symptoms is far milder than usually expected for acute and remarkable elevations of the serum Na level. It's striking that in one case among the reports above, lethargy developed in 2 weeks after the patient caught a common cold (Conley et al., 1976) . Of note is that our patient had a solid tumor adjacent to the adrenal gland with a pathological diagnosis of ganglioneuroma mainly composed of Na x -positive glial cells. Further, the patient had autoantibodies against Na x , the Na-level sensor in the brain involved in Na homeostasis (Noda, 2006 (Noda, , 2007 . The passive transfer of autoantibodies obtained from human patients to animals has been used to establish models of autoimmune etiology so far; for instance, myasthenic (and Lambert-Eaton) syndrome (Lang et al., 1981; Takamori et al., 1994) , cerebellar ataxia (Sillevis Smitt et al., 2000) , autoimmune autonomic neuropathy (Vernino et al., 2004) , and Pre-eclampsia (Zhou et al., 2008) . In the present study, mice injected with the patient's antibodies showed similar symptoms of hypernatremia, along with deposits of the autoantibodies to Na x and C3 complement factors, resulting in cell death specifically in the Na x -positive brain regions. Importantly, the patient's Ig fraction depleted with autoantibodies to Na x did not induce the symptoms, indicating that the autoantibodies are responsible for the disease. Thus, this is the first model of hypernatremia based on autoimmune pathology classified as a PND. This mechanism may contribute to a portion, if not all, of the pathological entity of so-called essential hypernatremia (or adipsic hypernatremia) without demonstrable hypothalamic structural lesion (Hayek and Peake, 1982) .
For hypernatremia, several potential pathogenetic mechanisms are known (Ross and Christie, 1969) . The most common and simple cause of hypernatremia is the taking of excessive salt, not enough water, or both (Adrogué and Madias, 2000) . When our patient stopped obligatory drinking of water for a few days, her plasma Na level increased over 160 mM ( Figure 1A ; for instance, day 84). This finding suggests that the patient is inclined to drink water insufficiently because of an absence of thirst and is probably inclined to ingest excessive salt, leading to a high plasma Na level. This abnormal behavior was reproduced in mice by passive transfer of the patient's Ig (Figure 4) . The basal water intake of the patient-Ig-injected mice under nonfeeding conditions was markedly small ( Figure 4A ). The patientIg-injected mice did not avoid Na-rich food, even when dehydrated by water supply restriction ( Figure 4E ), similarly to the Na x -KO mice (data not shown). Also, when the patient-Ig-injected mice were robustly dehydrated, they continued to ingest salt water like the Na x -KO mice did, and their plasma [Na + ] did not recover during the two-bottle preference test ( Figure 5 ). This abnormality in water/salt intake behavior would be one of the causes of hypernatremia of the patient.
In addition to the altered water/salt intake behavior, the patient-Ig-injected mice showed a reduction in the plasma-vasopressin response to dehydration ( Figure 4B ), which also resembles a symptom of the patient ( Figure 1E ). However, of note, the plasma vasopressin levels of Na x -KO mice are normal under dehydrated conditions (Nagakura et al., 2010) . This difference between Na x -KO and patient-Ig-injected mice suggests that autoantibodies to Na x not only affected the Na-level-sensing mechanisms mediated by Na x channels, but also impaired the regulatory systems for the production/release of vasopressin: Na x is expressed in glial cells including the ependymal cell in the SFO and OVLT (Watanabe et al., 2006) . The SFO and OVLT have projections to the SON and PVN, which are responsible for the regulation of vasopressin (Mangiapane et al., 1984; Thrasher et al., 1982) . Osmosensors, e.g. TRPV1 and TRPV4, are thought to be involved in the regulation of the activity of these projection neurons in the SFO, OVLT, or both (Ciura and Bourque, 2006; Liedtke et al., 2000) . Histological damage to the SFO and OVLT would be the reason for the dysregulation of vasopressin production/release. In addition, damage to the posterior pituitary, the site where vasopressin is released into the blood circulatory system, would also affect the release. This defect in the regulation of vasopressin appears to cause a more serious symptom for the patient.
The possibility of irreversible deficits in Na x -positive loci, including the SFO, OVLT, and posterior pituitary, was verified by increased cell death in the mice 3 days after the injection of the patient's Ig (Figure 7) . This notion was supported by not only the deposition of the complement component C3, suggestive of complement activation at these Na x -positive loci in the mice ( Figure 6B ), but also the infiltration of inflammatory cells with signals for CD68 and P2Y 12 at the same loci ( Figure 6C ). Furthermore, 14 days after the injection of the patient's Ig, we found that the SFO, OVLT, and posterior pituitary were partially degenerated in some mice (data not shown). These observations in the experimental animal model suggest that the SFO, OVLT, and posterior pituitary were attacked by the autoantibodies also in the patient. Supporting this view, C3 deposition and infiltration of CD68-positive inflammatory cells were observed in the ganglioneuroma resected from the patient ( Figure S7 ).
The binding of an autoantibody to a target on the cell surface has been known to trigger its internalization in cell-based assays (i.e., muscle acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis [Drachman et al., 1978] and neuronal NMDA receptor antibodies in encephalitis [Dalmau et al., 2008] ). We found that the patient's autoantibody induced substantial internalization of Na x channels from the plasma membrane of Na x -positive endogenous cells ( Figures 3B and  3C ) and C6 cells (see Supplemental Results and Figure S8 ). Along with the internalization of Na x from C6 cells, the cellular activities mediated by Na x , such as Na + influx and glucose uptake activity, were also decreased (see Supplemental Results and Figure S9 ).
The classical complement pathway is activated following interaction of an antigen-antibody complex with C1 component on the target cell surface. The pathway proceeds through the cascade to ultimately produce the membrane attack complex to lyse the cellular membrane. So it is conceivable that internalization of the antigen-autoantibody complex interferes with the progression of complement-mediated cell death. However, we found that robust cell death is induced in the cell-based assay using C6 cells by adding rabbit complement with the patient's serum, although this cytotoxic effect is indeed enhanced by pharmacological inhibition of the internalization (see Supplemental Results and Figure S10 ). This complement-mediated cell death likely occurred after one injection of the patient's Ig in the animal model, whereas it is probably ongoing in the patient.
Although we could not detect any apparent lesions by cytolysis in the CVOs or pituitary of the patient by MRI (Figure S2 ), the damage to these loci is considered to be not minor because the secretion of vasopressin in response to the patient's hyperosmolar state was markedly impaired ( Figure 1E ). As shown in Figure 2H , we found that the patient's serum still contained a certain amount of autoantibody to Na x even at 3 years and 4 years after the surgical removal of the Na x -positive tumor. Although the obligatory dinking of water is safe and has been effective in keeping the patient's serum Na level around upper normal levels to date, a trial to reduce or eliminate the autoantibody in our patient deserves consideration, in pursuit of a radical cure of the disorder. Strategies include the autoantibody elimination by double-filtration plasmapheresis or immunoadsorption therapy, and the administration of steroids, immunosuppressants, or rituximab (anti-CD20 antibody), although careful monitoring of adverse events and approval by the appropriate ethics committees are mandatory.
PNDs are a diverse group of diseases characterized by neurologic dysfunction in the setting of a remote cancer (Darnell and Posner, 2006) . The term ''paraneoplastic syndrome'' refers to symptoms or signs resulting from damage to organs or tissues at locations remote from the primary site of a neoplasm or any of its metastases. Here, the tumorigenesis is believed to initiate the syndrome by expressing a protein antigen normally expressed in the nervous system, leading to antitumor immune responses to induce autoimmune neurologic symptoms. The role of autoantibodies in neurological disorders generally involves action on the channel proteins. Such diseases are also referred to as ''autoimmune channelopathies'' (Vernino, 2007; Vincent et al., 2006) . Our study provides strong evidence for a novel PND in which tumor cells extensively expressing Na x channels induced the production of autoantibodies to Na x . Here, it is noteworthy that nonmyelinating Schwann cells in the peripheral nervous system (PNS) endogenously express Na x . The primary targets of the autoantibodies involved in the development of hypernatremia are most likely Na x -positive ependymal cells, astrocytes, and pituicytes in the SFO, OVLT, and posterior pituitary, which belong to the CVOs lacking a BBB where antibodies easily leak from the blood vessels (Broadwell and Sofroniew, 1993) .
In summary, this study demonstrated for the first time that a ganglioneuroma formed in the PNS triggered an autoimmune channelopathy targeting Na x , the Na-level sensor of body fluids in the brain, causing essential hypernatremia to develop. Pathogenetically, autoantibodies to Na x likely induce persistent tissue damage within the Na x -positive regions in the CVOs essential for systemic water/salt homeostasis through the activation of complement and infiltration of inflammatory cells.
EXPERIMENTAL PROCEDURES Authorization for Human Subject Research
The research protocol was approved by the ethics committee of Tokai University School of Medicine and Bioethics Inquiry Committee of the National Institute for Basic Biology. Informed consent was obtained from the subject's parents.
Experimental Animals
All the experiments with animals were carried out according to the guidelines of the National Institute for Basic Biology. WT (C57BL/6J, CLEA Japan, Tokyo, Japan) or homozygous Na x -KO males at 8-16 weeks of age were used for experiments. The mice were housed in plastic cages under a constant room temperature (23 C) with a 12 hr light/dark cycle (lights on at 8:00 a.m.) with ad libitum access to water and food (Rodent Diet CA-1, CLEA Japan).
Passive Transfer of the Ig Fraction into Mice
The Ig fraction was collected from the serum by precipitation with 33% saturated ammonium sulfate followed by dialysis against normal saline.
In some experiments, Ig fraction was preabsorbed using peptide columns (see Supplemental Experimental Procedures). Ig from the patient or a healthy control subject was intravenously injected into WT mice (2.5 mg IgG in 200 ml per 30 g body weight). The mice were used for the behavioral tests at 1 week after the injection. For the detailed procedures and the other methods, see the Supplemental Information. 
